NCT02274428.

Trial name or title	Phase 1 clinical trial of PNEUMOSTEM treatment in premature infants with intraventricular hemorrhage
Methods	Single group assignment; not a randomized controlled trial
Participants	Inclusion criteria: 23 to 34 weeks intraventricular hemorrhage grade 3 to 4, confirmed with brain ultrasonogram within 7 days after intraventricular hemorrhage diagnosis Exclusion criteria: severe congenital anomaly intrauterine intracranial bleeding intracranial infection severe congenital infection active and uncontrolled infection, C‐reactive protein > 10 mg/dL Platelet count < 50,000/mL severe metabolic acidosis (pH < 7.1, Base excess < ‐20)
Interventions	Drug: Pneumostem
Outcomes	Primary outcome measures: unsuspected death or anaphylactic shock within 6 hours after Pneumostem transplantation. Secondary outcome measures: death or hydrocephalus requiring shunt operation.
Starting date
Contact information
Notes	clinicaltrials.gov/ct2/show/NCT02274428 Study has passed its completion date and status has not been verified in more than 2 years.